Literature DB >> 7623788

Purification of histidine-tagged ras and its use in the detection of ras binding proteins.

T K Chataway1, G J Barritt.   

Abstract

Recombinant histidine-tagged v-Ha-ras (his-ras) was purified to homogeneity from extracts of E. coli M15 using a one-step procedure which involved immobilised metal ion chromatography on Ni(2+)-nitriloacetic acid agarose (Ni-NTA). The optimal pH for elution by imidazole was 6.6 and the yield of his-ras protein (greater than 95% pure) was about 4 mg/litre E. coli culture. Chromatography of a mixture of purified his-ras and rat brain cytosol on Ni-NTA together with SDS-PAGE and silver staining of proteins were employed to search for ras-binding proteins present in rat brain cytosol. Chromatography of rat brain cytosol alone on Ni-NTA revealed several protein species which were not readily eluted with imidazole. These are likely to be low-abundance brain metal ion binding proteins. Pre-treatment of rat brain cytosol with Ni-NTA before a second round of chromatography on Ni-NTA removed most of these proteins. Chromatography of a mixture of pre-treated rat brain cytosol and purified his-ras protein revealed four new protein bands with molecular weights of 250, 90, 80 and 70 kDa. These were considered to be candidate ras-binding proteins. It is concluded that the use of his-ras and immobilised metal ion chromatography does provide an approach which can be used to identify ras binding proteins present in cellular extracts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7623788     DOI: 10.1007/bf00944396

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

1.  Association of p21ras with cellular polypeptides.

Authors:  S Kaplan; D Bar-Sagi
Journal:  J Biol Chem       Date:  1991-10-05       Impact factor: 5.157

2.  Low molecular weight GTP-binding proteins in hepatocytes and an assessment of the role of p21ras proteins in the activation of phospholipase D.

Authors:  K M Hurst; T K Chataway; B P Hughes; G J Barritt
Journal:  Biochem Int       Date:  1991-06

3.  NIH-3T3 cells transformed with a ras oncogene exhibit a protein kinase C-mediated inhibition of agonist-stimulated Ca2+ inflow.

Authors:  A J Polverino; B P Hughes; G J Barritt
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The pathway to signal achievement.

Authors:  S E Egan; R A Weinberg
Journal:  Nature       Date:  1993-10-28       Impact factor: 49.962

Review 6.  Signal transduction pathways involving Ras. Mini review.

Authors:  L Wiesmüller; F Wittinghofer
Journal:  Cell Signal       Date:  1994-03       Impact factor: 4.315

7.  New metal chelate adsorbent selective for proteins and peptides containing neighbouring histidine residues.

Authors:  E Hochuli; H Döbeli; A Schacher
Journal:  J Chromatogr       Date:  1987-12-18

8.  Inhibition of Ca2+ inflow causes an abrupt cessation of growth-factor-induced repetitive free Ca2+ transients in single NIH-3T3 cells.

Authors:  A J Polverino; B P Hughes; G J Barritt
Journal:  Biochem J       Date:  1991-09-15       Impact factor: 3.857

9.  Identification of a protein associated with p21ras by chemical crosslinking.

Authors:  J de Gunzburg; R Riehl; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

10.  Expression of ras proto-oncogene proteins in normal human tissues.

Authors:  M E Furth; T H Aldrich; C Cordon-Cardo
Journal:  Oncogene       Date:  1987-03       Impact factor: 9.867

View more
  1 in total

1.  Activation of ras signaling pathway by 8-oxoguanine DNA glycosylase bound to its excision product, 8-oxoguanine.

Authors:  Istvan Boldogh; Gyorgy Hajas; Leopoldo Aguilera-Aguirre; Muralidhar L Hegde; Zsolt Radak; Attila Bacsi; Sanjiv Sur; Tapas K Hazra; Sankar Mitra
Journal:  J Biol Chem       Date:  2012-05-08       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.